Successfully De-risk Clinical Decision-Making, Standardize Spatial Biology Applications & Navigate Infrastructure & Data Challenges to Accelerate Workflows with Greater Accuracy & Return on Investment
As spatial biology technology advances, delivering unprecedented resolution, multiplexing, and reproducibility, new insights into disease biology are driving major breakthroughs across multiple therapeutic areas. Yet, key barriers still limit the full application of spatial biology in drug development. Overcoming these challenges is critical to achieving widespread adoption in research settings and beyond.
The 3rd Spatial Biology for Drug Development Summit offered delegates the opportunity to come together with leading biopharma experts to address these hurdles head-on. Across an intensive 2-day agenda, attendees explored practical solutions to issues spanning data infrastructure, multi-omics integration, standardization, scalability, and translation into the clinic. The 2025 forum equipped delegates with the latest data-driven strategies to not only overcome obstacles but to maximize the value of spatial biology for deeper disease insights, robust target identification, biomarker discovery, and more.
2025 Speakers
Attending Companies Included